Skip to Content

EC 35 (Risedronate Sodium Delayed-Release 35 mg)

Pill with imprint EC 35 is Yellow, Capsule-shape and has been identified as Risedronate Sodium Delayed-Release 35 mg. It is supplied by Actavis.

Risedronate is used in the treatment of osteoporosis; prevention of osteoporosis; paget's disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 35 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for EC 35

Risedronate sodium delayed-release 35 mg EC 35

Risedronate Sodium Delayed-Release

Imprint
EC 35
Strength
35 mg
Color
Yellow
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Bisphosphonates
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Actavis

Labelers / Repackagers

NDC Code Labeler / Repackager
00591-3876 Watson Pharmaceuticals, Inc.
00430-0979 Warner Chilcott

Get help with Imprint Code FAQs.

Related Images for "EC 35"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.